Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IP and IV Paclitaxel with Capecitabine for Gastric Cancer
NCT04034251Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- Jun 2020
- Primary completion
- Feb 2023
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection in gastric adenocarcinoma, sponsored by National Cancer Institute. Started Jun 2020; status: terminated.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT04034251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04034251.